Vitrolife AB (publ) – LSE:0YAY.L
Vitrolife AB (publ) stock price today
Vitrolife AB (publ) key metrics
Market Cap | 40.51B |
Enterprise value | 30.93B |
P/E | -7.83 |
EV/Sales | 8.70 |
EV/EBITDA | -9.56 |
Price/Sales | 8.39 |
Price/Book | 2.26 |
PEG ratio | -0.07 |
EPS | -28.34 |
Revenue | 3.49B |
EBITDA | 936M |
Income | -3.83B |
Revenue Q/Q | -1.52% |
Revenue Y/Y | 4.85% |
Profit margin | -107.09% |
Oper. margin | 21.59% |
Gross margin | 52.83% |
EBIT margin | 21.59% |
EBITDA margin | 26.76% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeVitrolife AB (publ) stock price history
Vitrolife AB (publ) stock forecast
Vitrolife AB (publ) financial statements
| Jun 2023 | 905M | 106M | 11.71% |
|---|---|---|---|
| Sep 2023 | 848M | 122M | 14.39% |
| Dec 2023 | 904M | -4.17B | -462.28% |
| Mar 2024 | 841M | 115M | 13.67% |
Paying a dividend while loss making.
| Payout ratio | -3.55% |
|---|
| 2019 | 0.43% |
|---|---|
| 2020 | |
| 2021 | 0.14% |
| 2022 | 0.43% |
| 2023 | 0.44% |
| Jun 2023 | 21648000000 | 3.96B | 18.33% |
|---|---|---|---|
| Sep 2023 | 21180000000 | 3.74B | 17.7% |
| Dec 2023 | 16391000000 | 3.66B | 22.38% |
| Mar 2024 | 16873000000 | 3.64B | 21.57% |
| Jun 2023 | 211M | -31M | -135M |
|---|---|---|---|
| Sep 2023 | 214M | -35M | -67M |
| Dec 2023 | 171M | -33M | 2M |
| Mar 2024 | 198M | -38M | -100M |
Vitrolife AB (publ) alternative data
| Aug 2023 | 1,102 |
|---|---|
| Sep 2023 | 1,102 |
| Oct 2023 | 1,102 |
| Nov 2023 | 1,109 |
| Dec 2023 | 1,109 |
| Jan 2024 | 1,109 |
| Feb 2024 | 1,109 |
| Mar 2024 | 1,123 |
| Apr 2024 | 1,123 |
| May 2024 | 1,132 |
| Jun 2024 | 1,132 |
| Jul 2024 | 1,132 |
Vitrolife AB (publ) other data
-
What's the price of Vitrolife AB (publ) stock today?
One share of Vitrolife AB (publ) stock can currently be purchased for approximately $299.2.
-
When is Vitrolife AB (publ)'s next earnings date?
Unfortunately, Vitrolife AB (publ)'s (0YAY.L) next earnings date is currently unknown.
-
Does Vitrolife AB (publ) pay dividends?
Yes, Vitrolife AB (publ) pays dividends and its trailing 12-month yield is 0.45% with -4% payout ratio.It means that the company is paying a dividend while loss making. The last Vitrolife AB (publ) stock dividend of undefined was paid on 3 Sep 2025.
-
How much money does Vitrolife AB (publ) make?
Vitrolife AB (publ) has a market capitalization of 40.51B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 8.6% to 3.51B US dollars.
-
What is Vitrolife AB (publ)'s stock symbol?
Vitrolife AB (publ) is traded on the LSE under the ticker symbol "0YAY.L".
-
What is Vitrolife AB (publ)'s primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Vitrolife AB (publ)?
Shares of Vitrolife AB (publ) can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Vitrolife AB (publ) have?
As Jul 2024, Vitrolife AB (publ) employs 1,132 workers, which is 1% more then previous quarter.
-
When Vitrolife AB (publ) went public?
Vitrolife AB (publ) is publicly traded company for more then 15 years since IPO on 24 Nov 2009.
-
What is Vitrolife AB (publ)'s official website?
The official website for Vitrolife AB (publ) is vitrolife.com.
-
How can i contact Vitrolife AB (publ)?
Vitrolife AB (publ) can be reached via phone at +46 31 721 80 00.
Vitrolife AB (publ) company profile:
Vitrolife AB (publ)
vitrolife.comLSE
1,111
Medical - Devices
Healthcare
Vitrolife AB (publ), a medical device company, develops, produces, and markets products for assisted reproduction. It provides oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products. The company also offers EmbryoScope and Primo Vision time-lapse systems; time-lapse dishes; evaluation tools for time-lapse systems; and Octax laser and imaging systems, as well as log and guard systems and wireless sensors. It operates in Europe, the Middle East, and Africa; Asia; Japan and Pacific; and North and South America. The company was formerly known as Scandinavian IVF Science and changed its name to Vitrolife AB (publ) in 1998. Vitrolife AB (publ) was founded in 1994 and is headquartered in Gothenburg, Sweden.
Gothenburg, 421 32
:
:
:
